Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

ENGINEERING LOW-COST PRODUCTION OF TACCALONOLIDES TO OVERCOME CANCER DRUG RESISTANCE

EF 2023-24

Résumé
Cancer consistently ranks as a global leading cause of death despite decades of administering treatments. The initial success of chemotherapy introduced over 70 years ago quicky stagnated, mainly due to a phenomenon called cancer drug resistance. Very frequently tumors develop a resistance against anticancer medication, leading to a relapse of cancers in patients which increases mortality. The current anticancer drug portfolio is limited in terms of circumventing the acquired and innate cancer drug resistance - it is thus urgent to develop novel therapies. As it turns out the solution may be found in nature through plant natural products. Humanity has been using plant extracts for medical purposes for millennia, as seen in traditional Chinese medicines. Taccalonolides which are derived from rhizomes of the Tacca family of plants, commonly known as the bat flower, are good examples. They are particularly attractive as chemotherapeutics candidates because they can bypass the mechanisms behind drug resistance. Manufacturing this natural product at a large-scale is restrained by the low-yielding and costly plant extraction processes and chemical synthesis methods. To overcome these challenges, this project proposes an alternative strategy based on synthetic biology and computational biology to discover the biosynthetic pathway of taccalonolide, or in other words, finding the genes responsible for the production of this compound. This series of genes can then be reconstructed in microbial cells like yeast, which would allow large-scale production of taccalonolides by fermentation bioproduction. This approach unlocks the development of a cheap and environmentally sustainable mode of production of taccalonolides to solve the urgent issues of cancer drug resistance.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506324
Name
Seyedmoomenkashi Justin
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
ENGINEERING LOW-COST PRODUCTION OF TACCALONOLIDES TO OVERCOME CANCER DRUG RESISTANCE
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Drug Discovery; Drug Resistance; Metabolic Engineering; Metabolomics; Natural Products; Plant Biotechnology; Sustainability; Synthetic Biology; Transcriptomics
Abstract
Cancer consistently ranks as a global leading cause of death despite decades of administering treatments. The initial success of chemotherapy introduced over 70 years ago quicky stagnated, mainly due to a phenomenon called cancer drug resistance. Very frequently tumors develop a resistance against anticancer medication, leading to a relapse of cancers in patients which increases mortality. The current anticancer drug portfolio is limited in terms of circumventing the acquired and innate cancer drug resistance - it is thus urgent to develop novel therapies. As it turns out the solution may be found in nature through plant natural products. Humanity has been using plant extracts for medical purposes for millennia, as seen in traditional Chinese medicines. Taccalonolides which are derived from rhizomes of the Tacca family of plants, commonly known as the bat flower, are good examples. They are particularly attractive as chemotherapeutics candidates because they can bypass the mechanisms behind drug resistance. Manufacturing this natural product at a large-scale is restrained by the low-yielding and costly plant extraction processes and chemical synthesis methods. To overcome these challenges, this project proposes an alternative strategy based on synthetic biology and computational biology to discover the biosynthetic pathway of taccalonolide, or in other words, finding the genes responsible for the production of this compound. This series of genes can then be reconstructed in microbial cells like yeast, which would allow large-scale production of taccalonolides by fermentation bioproduction. This approach unlocks the development of a cheap and environmentally sustainable mode of production of taccalonolides to solve the urgent issues of cancer drug resistance.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Seyedmoomenkashi, Justin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~